WASHINGTON, D.C. – Today the U.S. Chamber of Commerce’s U.S.-Israel Business Initiative released a paper entitled “U.S.-Israel Collaboration in Health Innovation” that provides policy recommendations to advance greater coordination in health technology and innovation between the United States and Israel.
Amid the COVID-19 pandemic, the U.S.-Israel Business Initiative created a working group in coordination with leading global companies, policymakers, medical experts, academics, and more to serve as a platform for a dialogue on emerging health innovations in Israel. The report released today includes policy proposals from the working group to bolster collaboration in Israel on a variety of areas including digital health, pharmaceutical research and development, medical devices, and cybersecurity of critical health infrastructure.
“The United States and Israel are leading hubs for health-related technology,” said Josh Kram, Executive Director of Middle East Affairs at the U.S. Chamber of Commerce. “As we’ve seen the COVID-19 pandemic continue to pose some of the greatest health challenges of our time, it is important to build partnerships in Israel between health care professionals, policymakers, and the private sector. The paper released today highlights how the U.S. can collaboratively help advance health technology and innovation in Israel.”
The paper has been shared with both U.S. and Israel government agencies and can be found online here.
The U.S.-Israel Business Initiative (USIBI) at the U.S. Chamber of Commerce is the premier national business advocacy organization dedicated to strengthening the trade, investment, and innovation relationship between the U.S. and Israel.
